Patents by Inventor Eric K. Rowinsky

Eric K. Rowinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a receptor-type kinase modulator for treating polycystic kidney disease
    Patent number: 9956221
    Abstract: The invention comprises a method of treating polycystic kidney disease (PKD) in a mammal, such as a human or feline (e.g., Persian cat), comprising administering a therapeutically effective amount of the compound of formula to the mammal. Also provided are uses of the compound for preparation of a medicament for treating PKD and the above compound and compositions comprising it for treating PKD.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: May 1, 2018
    Assignee: SYMPHONY EVOLUTION, INC.
    Inventors: Philip Frost, William W. N. Liao, Eric K. Rowinsky
  • Use of a Receptor-Type Kinase Modulator for Treating Polycystic Kidney Disease
    Publication number: 20160367555
    Abstract: The invention comprises a method of treating polycystic kidney disease (PKD) in a mammal, such as a human or feline (e.g., Persian cat), comprising administering a therapeutically effective amount of the compound of formula to the mammal. Also provided are uses of the compound for preparation of a medicament for treating PKD and the above compound and compositions comprising it for treating PKD.
    Type: Application
    Filed: May 18, 2016
    Publication date: December 22, 2016
    Inventors: Philip Frost, William W. N. Liao, Eric K. Rowinsky
  • Use of a receptor-type kinase modulator for treating polycystic kidney disease
    Patent number: 9364479
    Abstract: The invention comprises use of a therapeutically effective amount of the compound of the formula below for preparation of a medicament for treating polycystic kidney diseases (PKD) in a mammal, such as human or feline (e.g., Persian cat). Formula (I). Also provided are the above compound and compositions comprising it for treating PKD.
    Type: Grant
    Filed: August 25, 2011
    Date of Patent: June 14, 2016
    Assignee: SYMPHONY EVOLUTION, INC.
    Inventors: Philip Frost, William W. N. Liao, Eric K. Rowinsky
  • Use of a Receptor-Type Kinase Modulator for Treating Polycystic Kidney Disease
    Publication number: 20130217711
    Abstract: The invention comprises use of a therapeutically effective amount of the compound of the formula below for preparation of a medicament for treating polycystic kidney diseases (PKD) in a mammal, such as human or feline (e.g., Persian cat).Formula (I). Also provided are the above compound and compositions comprising it for treating PKD.
    Type: Application
    Filed: August 25, 2011
    Publication date: August 22, 2013
    Applicant: SYMPHONY EVOLUTION, INC.
    Inventors: Philip Frost, William W. N. Liao, Eric K. Rowinsky
  • Compound, composition and method for treating cancer
    Patent number: 6235761
    Abstract: Substantially pure 3,5-dichloro-2-nethoxy-4-hydroxy-6-(trichloromethyl)pyridine or 4-demethylpenclomedine (formula I), acid addition salts thereof, pharmaceutical compositions containing the aforesaid compound, and a method of using the compound in the treatment of cancer in a mammal are disclosed.
    Type: Grant
    Filed: February 22, 1999
    Date of Patent: May 22, 2001
    Inventors: Neil Hartman, Robert F. Struck, Seamus O'Reilly, John M. Strong, Eric K. Rowinsky, Jerry M. Collins